784843006: Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Clindamycin + Tretinoin\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)

\Medicinal product\Product manufactured as cutaneous dose form\Product containing tretinoin in cutaneous dose form (medicinal product form)\Product containing clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Product manufactured as cutaneous dose form\Product containing clindamycin in cutaneous dose form (medicinal product form)\Product containing clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing clindamycin\Product containing clindamycin in cutaneous dose form (medicinal product form)\Product containing clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing clindamycin\Product containing clindamycin and tretinoin\Product containing clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing clindamycin\Product containing clindamycin and tretinoin\Clindamycin + Tretinoin\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrrolidine\Product containing clindamycin\Product containing clindamycin in cutaneous dose form (medicinal product form)\Product containing clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrrolidine\Product containing clindamycin\Product containing clindamycin and tretinoin\Product containing clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrrolidine\Product containing clindamycin\Product containing clindamycin and tretinoin\Clindamycin + Tretinoin\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing terpene\Product containing retinoid\Product containing tretinoin\Product containing tretinoin in cutaneous dose form (medicinal product form)\Product containing clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing terpene\Product containing retinoid\Product containing tretinoin\Product containing clindamycin and tretinoin\Product containing clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing terpene\Product containing retinoid\Product containing tretinoin\Product containing clindamycin and tretinoin\Clindamycin + Tretinoin\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Product containing clindamycin\Product containing clindamycin in cutaneous dose form (medicinal product form)\Product containing clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Product containing clindamycin\Product containing clindamycin and tretinoin\Product containing clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Product containing clindamycin\Product containing clindamycin and tretinoin\Clindamycin + Tretinoin\Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)\Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

4596613012 Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel en Synonym Active Entire term case insensitive SNOMED CT core module

4596614018 Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has precise active ingredient	Tretinoin	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength numerator unit	nanogram	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has manufactured dose form	Conventional release cutaneous gel	true	Inferred relationship	Existential restriction modifier
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has basis of strength substance	Clindamycin phosphate	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength denominator unit	milligram	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength numerator value	12	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has precise active ingredient	Clindamycin phosphate	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength denominator unit	milligram	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength numerator unit	microgram	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has basis of strength substance	Tretinoin	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength numerator value	250	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength denominator value	1	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Is a	Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Plays role	Antibacterial therapeutic role	true	Inferred relationship	Existential restriction modifier
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength denominator unit	gram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength numerator unit	microgram	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength denominator unit	gram	true	Inferred relationship	Existential restriction modifier	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
4596613012	Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
4596614018	Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module